Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Completed × chiauranib × Clear all

Phase

Phase 1/2 3 Phase 2 2 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Exercise 168 Magnetic Resonance Spectroscopy 101 Surveys and Questionnaires 100 Blood Specimen Collection 99 Standard of Care 92 Early Intervention, Educational 85 Methods 83 Educational Status 83 Radiotherapy 82 Radiosurgery 68 Counseling 62 Control Groups 57 Acupuncture Therapy 54 Psychiatric Rehabilitation 45 Biopsy 43 Palliative Care 41 Therapeutics 40 Resistance Training 40 Cyclophosphamide 40 Yoga 38 Saline Solution 38 Cognitive Behavioral Therapy 37 Drug Therapy 34 Practice Guidelines as Topic 33 Surgical Procedures, Operative 32 Metformin 32 Interviews as Topic 31 Radiofrequency Ablation 30 Patient Navigation 30 Magnetic Resonance Imaging 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05371899 2024-07-15

Mass Balance Study of [14C]Chiauranib

Chipscreen Biosciences, Ltd.

Phase NA Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡